Stockscreener 앱 받기
2.57
0.00%
0.00
시간 외 거래:
2.57
Alector Inc 주식(ALEC)의 최신 뉴스
Transcript : Alector, Inc.Special Call - marketscreener.com
MSN Money - MSN
Five-Way Obesity Drug Shows Effectiveness in Mice; Alector Stops Alzheimer’s Trial - geneonline.com
Morgan Stanley raises Alector stock price target on pipeline focus By Investing.com - Investing.com South Africa
Morgan Stanley raises Alector stock price target on pipeline focus - Investing.com
Analysts Offer Insights on Healthcare Companies: Establishment Labs Holdings (ESTA) and Alector (ALEC) - The Globe and Mail
Failure of GSK-partnered Alzheimer’s drug a fresh setback for Alector - The Pharma Letter
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC) and Alector (ALEC) - The Globe and Mail
Peninsula biotech Alector loses another Alzheimer's battle, shifts to earlier-stage programs - The Business Journals
Alector drops GSK-partnered Alzheimer’s drug (ALEC:NASDAQ) - Seeking Alpha
How The Alector (ALEC) Narrative Is Shifting Toward BBB Shuttle Programs And Execution Risk - Yahoo Finance
GSK-partnered Alector hit with third neuro failure as Alzheimer’s asset disappoints - BioSpace
5AM Venture Management, LLC's Alector Inc(ALEC) Holding History - GuruFocus
[EFFECT] Alector, Inc. SEC Filing - Stock Titan
Biopharmaceutical company Alector Inc. announced that it will discontinue its Phase II PROGRESS-AD clinical trial of its candidate drug Nivisnebart (development code AL101/GSK4527226) for the treatment of early-stage Alzheimer's disease. - Bitget
Alector to discontinue phase 2 trial of nivisnebart - marketscreener.com
Alzheimer’s drug study stops early after review finds low odds of success - Stock Titan
Cantor Fitzgerald upgrades Alector (ALEC) - MSN
Alector (NASDAQ: ALEC) sets 2026 virtual meeting on directors, auditor and say-on-pay - Stock Titan
BlackRock (ALEC) discloses 5.2% ownership of Alector common stock - Stock Titan
Alector gains as Cantor Fitzgerald upgrades on brain carrier platform - MSN
Alector (ALEC)'s technical outlook is bright after key golden cross - MSN
Alector (ALEC) Price Target Decreased by 42.61% to 2.24 - MSN
Alector upgraded at Mizuho on high risk/higher-reward - MSN
Alector (ALEC) Stock: Future Performance Expectations (Buying Pressure) 2026-04-20Elite Alerts - UBND thành phố Hải Phòng
Alector (ALEC) Stock: Why It Matters Now (Trades Higher) 2026-04-20Bearish Pattern - Xã Thanh Hà
Insider Sell: Grace Wong-sarad Sells Shares of Alector Inc (ALEC) - GuruFocus
Alector Inc: Principal accounting officer Wong-Sarad sells $4823 in stock - Investing.com India
Alector Inc: Principal accounting officer Wong-Sarad sells $4823 in stock By Investing.com - Investing.com South Africa
Alector (ALEC) accounting officer sells 1,820 shares in 10b5-1 trade - Stock Titan
ALEC (NASDAQ: ALEC) affiliate reports multiple common-stock sales in Mar 2026 - Stock Titan
This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
Alector stock upgraded at Cantor Fitzgerald (ALEC:NASDAQ) - Seeking Alpha
ALEC Upgraded by Cantor Fitzgerald -- Rating Raised to Overweigh - GuruFocus
Cantor Fitzgerald Upgrades Alector (NASDAQ:ALEC) to "Overweight" - MarketBeat
1.77%
0.25%
자본화:
|
볼륨(24시간):